Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Kim

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|February 12, 2026
Discovery and In Vivo Evaluation of Aryl Ether YAP1/TEAD Inhibitors for the Treatment of Hippo-Driven MalignanciesBrandon A Vara, Jongwon Lim, Casey J Moure, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2017
Discovery of novel BTK inhibitors with carboxylic acidsXiaolei Gao, James Wang, Jian Liu, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Discovery of 8-Amino-imidazo[1,5-a]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid ArthritisJian Liu, Deodial Guiadeen, Arto Krikorian, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutesJian Liu, Deodial Guiadeen, Arto Krikorian, et al.
Nature Genetics|April 5, 2011
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's diseaseAdam C Naj, Gyungah Jun, Gary W Beecham, et al.
Neurology|June 23, 2012
Novel late-onset Alzheimer disease loci variants associate with brain gene expressionMariet Allen, Fanggeng Zou, High Seng Chai, et al.
JAMA Neurology|September 10, 2014
Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association studyAdam C Naj, Gyungah Jun, Christiane Reitz, et al.
JAMA Neurology|December 23, 2014
Rarity of the Alzheimer disease-protective APP A673T variant in the United StatesLi-San Wang, Adam C Naj, Robert R Graham, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies <i>LRRC4C, LHX5-AS1</i> and nominates ancestry-specific loci <i>PTPRK</i> , <i>GRB14</i> , and <i>KIAA0825</i> as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics ConsortiumFarid Rajabli, Penelope Benchek, Giuseppe Tosto, et al.
Genome Biology|July 17, 2025
Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer's diseaseFarid Rajabli, Penelope Benchek, Giuseppe Tosto, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|February 12, 2026
Discovery and In Vivo Evaluation of Aryl Ether YAP1/TEAD Inhibitors for the Treatment of Hippo-Driven MalignanciesBrandon A Vara, Jongwon Lim, Casey J Moure, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2017
Discovery of novel BTK inhibitors with carboxylic acidsXiaolei Gao, James Wang, Jian Liu, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Discovery of 8-Amino-imidazo[1,5-a]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid ArthritisJian Liu, Deodial Guiadeen, Arto Krikorian, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutesJian Liu, Deodial Guiadeen, Arto Krikorian, et al.
Nature Genetics|April 5, 2011
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's diseaseAdam C Naj, Gyungah Jun, Gary W Beecham, et al.
Neurology|June 23, 2012
Novel late-onset Alzheimer disease loci variants associate with brain gene expressionMariet Allen, Fanggeng Zou, High Seng Chai, et al.
JAMA Neurology|September 10, 2014
Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association studyAdam C Naj, Gyungah Jun, Christiane Reitz, et al.
JAMA Neurology|December 23, 2014
Rarity of the Alzheimer disease-protective APP A673T variant in the United StatesLi-San Wang, Adam C Naj, Robert R Graham, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies <i>LRRC4C, LHX5-AS1</i> and nominates ancestry-specific loci <i>PTPRK</i> , <i>GRB14</i> , and <i>KIAA0825</i> as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics ConsortiumFarid Rajabli, Penelope Benchek, Giuseppe Tosto, et al.
Genome Biology|July 17, 2025
Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer's diseaseFarid Rajabli, Penelope Benchek, Giuseppe Tosto, et al.
Pageof 6